Trevi Therapeutics Inc.

12/12/2024 | Press release | Distributed by Public on 12/12/2024 06:31

Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.